|
(BS28) |
Non-invasive imaging of early venous thrombosis by 19F MRI using targeted perfluorocarbon nanoemulsions |
| |
|
S. Temme, C. Grapentin, C. Quast, C. Jacoby, M. Grandoch, Z. Ding, F. Mayenfels, J. W. Fischer, R. Schubert, J. Schrader, U. Flögel (Düsseldorf, Freiburg im Breisgau) |
|
(BS29) |
Cardiomyocytes from parthenogenetic stem cells differentiated in engineered heart muscle express major histocompatibility complex-I only after interferon gamma stimulation. |
| |
|
S. Galla, M. Didie, V. Muppala, R. Dressel, W.-H. Zimmermann (Göttingen, Goettingen) |
|
(BS30) |
Cell culture conditions modify cardiac fibroblasts towards cardioprotective cells |
| |
|
S. van Linthout, K. Miteva, O. Klein, M. Haag, C. Zietsch, J. Klose, M. Sittinger, C. Tschöpe (Berlin) |
|
(BS31) |
Adverse effect of interferon γ to the formation of myofibroblasts |
| |
|
K. Pappritz, K. Savvatis, C. Zietsch, H.-P. Schultheiss, C. Tschöpe (Berlin) |
|
(BS32) |
Role of cGMP dependent protein kinases in the renal antifibrotic effect of Serelaxin |
| |
|
V. Wetzl, L. Faerber, F. Hofmann, E. Schinner, J. Schlossmann (Regensburg, München) |
|
(BS33) |
Identification and functional characterization of GATA2-regulated microRNAs |
| |
|
D. Hartmann, K. Sonnenschein, J. Fiedler, T. Thum (Hannover) |
|
(BS34) |
Altering Tissue Functionality using growth factors and small molecules in a Bioengineered Heart Muscle |
| |
|
F. Raad, A. Roa, J. Hudson, W.-H. Zimmermann (Göttingen; Brisbane, AU) |
|
(BS35) |
Paracrine support of engineered heart muscle using pharmacologically inducible IGF1 |
| |
|
P. L. Soong, M. Tiburcy, J. Christoph, S. Luther, F. Jebran, F. Schöndube, W.-H. Zimmermann (Göttingen) |
|
(BS36) |
The insulin growth factor binding protein 5 (Igfbp5), a potential Wnt/β-catenin target in early cardiogenesis and cardiac remodeling |
| |
|
M. Wölfer, A. Renger, J. Wenthe, L. Zelarayán (Göttingen) |
|
(BS37) |
Effects of DPP4-inhibition on endothelial function and hemostasis in a rodent model of septic shock |
| |
|
S. Steven, M. Hausding, S. Kröller-Schön, Y. Mikhed, M. Oelze, T. Münzel, A. Daiber (Mainz) |
|
(BS38) |
Epicardium-derived cells effectively degrade nucleotides to adenosine and tenascin-C - mediated inhibition of CD73 stimulates their migration |
| |
|
J. Hesse, E. Boden, D. Friebe, B. Steckel, Z. Ding, J. Schrader (Düsseldorf) |